NCTN Assessment on Current Applications of Radiomics in Oncology

Radiomics is a fast-growing research area based on converting standard-of-care imaging into quantitative minable data and building subsequent predictive models to personalize treatment. It has been proposed as a study objective in clinical trial concepts and a potential biomarker for stratifying patients across interventional treatment arms. In recognizing the growing importance of radiomics in oncology a group of medical physicists and clinicians from NRG Oncology reviewed the current status of the field and identified critical issues, providing general assessment and early recommendations for incorporation in oncology studies.

http://bit.ly/2HKvw4l